News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NetRegulus Enterprise Regulatory Management Software Selected by Ablation Frontiers to Support Next Phase of Clinical Trials


7/24/2007 8:32:26 AM

CENTENNIAL, Colo. and CARLSBAD, Calif., July 24 /PRNewswire/ -- NetRegulus(R), Inc., a leading provider of enterprise compliance software for the life science industry, today announced that Ablation Frontiers, Inc., an innovative leader in technology development for arrhythmia management, has selected the NetRegulus solution to manage the next phase of the company's aggressive clinical trial schedule. The adoption of NetRegulus' NetRM(TM) solution will provide Ablation Frontiers with the tools to more quickly and effectively manage their clinical trial program. The Software as a Service (SaaS) solution saves upfront investments in time and resources as well as the costs normally associated with the deployment of leading edge clinical study solutions.

"NetRegulus' experience and significant knowledge of regulated life sciences was a key factor in our decision process. Our goal was to successfully manage critical trial data in preparation for successful FDA submissions but also to do it in a cost efficient and expedient way to potentially reduce our time to market. Our experience to date with the NetRegulus team has been very satisfying," said Ablation Frontiers Director of Clinical Affairs, Jerry Cox.

"The NetRegulus NetRM(TM) technology not only allowed us to create the FDA 21 CFR Part 11 compliant case report forms and launch Ablation Frontier's study in a time-sensitive situation, but to do so in a cost-effective manner," said Mike Prudhomme, NetRegulus' Chief Technology Officer. "We view Ablation Frontiers as an innovator in cardiac therapy, and we are very proud to contribute to their work in this exciting, emerging market."

About Ablation Frontiers, Inc.

Ablation Frontiers is an early-stage venture capital funded medical device company located in Carlsbad, California developing innovative technologies in cardiac rhythm management. They are currently involved in several multi-national clinical trials focusing on atrial fibrillation and have recently received a CE Mark for their Cardiac Ablation System.

About NetRegulus, Inc.

Headquartered in Centennial, CO, NetRegulus (http://www.netregulus.com) is a leading provider of web-based Enterprise Regulatory Management software that allows Life Science companies to effectively manage their clinical, study and quality data with solutions that provide organizations with the ability to manage complex data requirements -- from clinical trials through regulated post market activities -- within a single integrated and modular system. The NetRegulus NetRM(TM) solutions help Life Science companies meet ever increasing global regulatory requirements and to improve operational efficiencies, launch products to market faster and proactively identify potential product quality problems.

For additional information, contact: Lisa Ensign, Director of Clinical and Study Solutions lisa.ensign@netregulus.com 888-707-6900

NetRegulus, Inc.

CONTACT: Lisa Ensign, Director of Clinical and Study Solutions ofNetRegulus, Inc., 1-888-707-6900, lisa.ensign@netregulus.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES